Ainos, Inc.

AIMD
$2.04 (+ $0.16 + 8.51%)
Last updated: 2026-06-18 06:43 UTC
AIMD Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorTechnology
IndustryScientific & Technical Instruments
ISINUS00902F4028
CUSIP00902F402
Market Price2.04
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-3.92
Market Cap$9.7M
Book Value2.1
Price to Book0.959
Beta2.4
52w High5.0
52w Low1.78
Next Earnings DateN/A

Ainos, Inc. trades under ticker AIMD on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Technology exposure. Identifiers: ISIN US00902F4028, CUSIP 00902F402.

About the Company
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
Price History